Skip to main content
. Author manuscript; available in PMC: 2012 Jun 1.
Published in final edited form as: Obstet Gynecol. 2011 Jun;117(6):1341–1348. doi: 10.1097/AOG.0b013e31821aa739

Table 2.

Unadjusted and Adjusted Risk Estimates for IUGR and IUFD in Fetuses With Echogenic Bowel Compared to Those Without Echogenic Bowel After Excluding Cases of Aneuploidy and CMV Infection

Incidence in EB group (n=231) Incidence in Non-EB group (n=49,940) Unadjusted RR (95% CI) aOR (95% CI) p-value
IUGR 19.5% 12.9% 1.6 (1.2–2.0) 2.1* (1.5–2.9) <0.001
IUFD 7.3% 0.9% 8.0 (5.0–12.8) 9.6 (5.8–15.9) <0.001
IUFD+IUGR 6.1% 0.2% 27.5 (16.0–47.2) --- ---
IUFD-IUGR 1.3% 0.2% 6.2 (2.0–19.2) --- ---
*

Adjusted for African American race, tobacco use, pre-eclampsia and pre-gestational diabetes

Adjusted for African American race

P-values are from the Wald test of the adjusted odds ratios.

IUGR=intrauterine growth restriction; IUFD=intrauterine fetal demise; EB=echogenic bowel; CMV=cytomegalovirus; RR=relative risk; aOR=adjusted odds ratio; CI=confidence interval